CSIMarket
 
Icagen, Inc.  (ICGND)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Icagen's Customers Performance

ICGND



 
ICGND's Source of Revenues During the corresponding time, Icagen, Inc. recorded a revenue increase by 19.66 % year on year, sequentially revenue fell by -7.84 %. While revenue at the Icagen, Inc.'s corporate clients

• List of ICGND Customers




for the same period Icagen, Inc. recorded revenue increase by 19.66 % year on year, sequentially revenue fell by -7.84 %.

• List of ICGND Customers

Icagen's Business Units






Icagen's Comment on Sales, Marketing and Customers
















ICGND's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Icagen, Inc. 0.00 14.08 -14.42 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Icagen, Inc.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Icagen, Inc.’s corporate clients.
For your research, we’ve provided 9 tables on Icagen, Inc. corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.